Activation of neutral sphingomyelinase by IL-1beta requires the type 1 interleukin 1 receptor

Cytokine. 2000 Mar;12(3):229-32. doi: 10.1006/cyto.1999.0547.

Abstract

The cytokine interleukin 1beta (IL-1beta) plays an important role in host defence reactions and neuro-immune interactions but it is still not clear which of the two interleukin 1 receptor subtypes is coupled to activation of neutral sphingomyelinase (nSMase) by IL-1beta. To investigate involvement of neutral sphingomyelinase (nSMase) in central IL-1beta effects we used P(2)fractions of brain cerebral cortex from wild-type mice and mice deficient in the type 1 IL-1 receptor. IL-1beta (human, recombinant) was shown to activate, in a dose-dependent manner, nSMase in the P(2)brain fraction of the wild-type mice while in the knock-out mice the stimulatory effect of IL-1beta on nSMase was absent. In the presence of an IL-1 receptor antagonist (IL-1ra), IL-1beta did not activate nSMase either in the cortex of wild-type or knock-out mice. These data suggest that nSMase, a key enzyme of the sphingomyelin signal transduction pathway, might be involved in IL-1beta signalling in the brain and that activation of the enzyme requires the IL-1 receptor type 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cerebral Cortex / metabolism
  • Enzyme Activation
  • In Vitro Techniques
  • Interleukin-1 / physiology*
  • Mice
  • Mice, Knockout
  • Receptors, Interleukin-1 / physiology*
  • Receptors, Interleukin-1 Type I
  • Signal Transduction
  • Sphingomyelin Phosphodiesterase / metabolism*

Substances

  • Interleukin-1
  • Receptors, Interleukin-1
  • Receptors, Interleukin-1 Type I
  • Sphingomyelin Phosphodiesterase